Pantaleo G, Fauci A S
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Maryland 20892-1876, USA.
Annu Rev Microbiol. 1996;50:825-54. doi: 10.1146/annurev.micro.50.1.825.
The rate of progression of HIV disease may be substantially different among HIV-infected individuals. Following infection of the host with any virus, the delicate balance between virus replication and the immune response to the virus determines both the outcome of the infection, i.e. the persistence versus elimination of the virus, and the different rates of progression. During primary HIV infection, a burst of viremia occurs that disseminates virus to the lymphoid organs. A potent immune response ensues that substantially, but usually not completely, curtails virus replication. This inability of the immune system to completely eliminate the virus leads to establishment of chronic, persistent infection that over time leads to profound immunosuppression. The potential mechanisms of virus escape from an otherwise effective immune response have been investigated. Clonal deletion of HIV-specific cytotoxic T-cell clones and sequestration of virus-specific cytotoxic cells away from the major site of virus replication represent important mechanisms of virus escape from the immune response that favor persistence of HIV. Qualitative differences in the primary immune response to HIV (i.e. mobilization of a restricted versus broader T-cell receptor repertoire) are associated with different rates of disease progression. Therefore, the initial interaction between the virus and immune system of the host is critical for the subsequent clinical outcome.
HIV感染个体中HIV疾病的进展速度可能存在显著差异。宿主被任何病毒感染后,病毒复制与对病毒的免疫反应之间的微妙平衡决定了感染的结果,即病毒的持续存在与清除,以及不同的进展速度。在原发性HIV感染期间,会出现一阵病毒血症,将病毒传播到淋巴器官。随之而来的是强烈的免疫反应,这种反应会大幅但通常不会完全抑制病毒复制。免疫系统无法完全清除病毒导致了慢性持续性感染的建立,随着时间的推移会导致严重的免疫抑制。人们已经对病毒从原本有效的免疫反应中逃逸的潜在机制进行了研究。HIV特异性细胞毒性T细胞克隆的克隆性清除以及病毒特异性细胞毒性细胞与病毒复制主要部位的隔离,是病毒从免疫反应中逃逸的重要机制,有利于HIV的持续存在。对HIV的原发性免疫反应的质量差异(即动员有限或更广泛的T细胞受体库)与不同的疾病进展速度相关。因此,病毒与宿主免疫系统之间的初始相互作用对随后的临床结果至关重要。